Table 1.
Summary of Organizational Characteristics of Non-EU Agencies
| All agencies | MD specific | Non-MD specific | ||||
|---|---|---|---|---|---|---|
| (N = 36)a | agencies (N = 27)a | Agencies (N = 9)a | ||||
| Characteristics | N | Median (range) | N | Median (range) | N | Median (range) |
| Annual funding (million USD) | 20 | 2.1 (0.01–24.2) | 15 | 2.3 (0.01—24.20) | 5 | 1.0 (0.4–21.0) |
| Number of staff | 31 | 25 (3–150) | 24 | 19 (3–150) | 7 | 30 (19- 66) |
| N (%) | N (%) | N (%) | ||||
| Type of organization | ||||||
| National/Central/Federal Government | 16 (44) | 13 (48) | 3 (33) | |||
| Local/Provincial/State Government | 2 (6) | 2 (7) | 0 (0) | |||
| Academia/university | 4 (11) | 3 (11) | 1 (11) | |||
| Compulsory health care insurance (public) | 0 (0) | 0 (0) | 0 (0) | |||
| Private medical insurance | 1 (3) | 1 (4) | 0 (0) | |||
| Hospital | 1 (3) | 1 (4) | 0 (0) | |||
| Professional association | 0 (0) | 0 (0) | 0 (0) | |||
| Other not-for-profit | 7 (19) | 4 (15) | 3 (33) | |||
| Other | 5 (14) | 3 (11) | 2 (22) | |||
| Source of funding | ||||||
| National/Local Governmentb | 31 (86) | 22 (81) | 9 (100) | |||
| Private institutionsb | 8 (22) | 6 (22) | 2 (22) | |||
| Donor agencies (foundations, research funding bodies, international agencies)b | 7 (19) | 3 (11) | 4 (44) | |||
| Otherb | 9 (25) | 7 (26) | 2 (22) | |||
| Professional background of staff | ||||||
| Clinical specialist/physician | 31 [of 32] (97) | 24 [of 25] (96) | 7 [of 7] (100) | |||
| Economist | 26 [of 32] (81) | 20 [of 25] (80) | 6 [of 7] (86) | |||
| Epidemiologist/statistician | 26 [of 32] (81) | 20 [of 25] (80) | 6 [of 7] (86) | |||
| Information specialist | 19 [of 32] (59) | 15 [of 25] (60) | 4 [of 7] (57) | |||
| Other | 27 [of 32] (84) | 22 [of 25] (88) | 5 [of 7] (71) | |||
| Responsible for/contributes to decision-making | 15 (42) | 12 (44) | 3 (33) | |||
| Technologies assessed/appraised | ||||||
| Drugs (pharmaceuticals, biologicals, vaccines) | 25 (69) | 17 (63) | 8 (89) | |||
| Medical devices | 36 (100) | 27 (100) | 9 (100) | |||
| Diagnostics | 31 [of 33] (94) | 23 [of 25] (92) | 8 [of 8] (100) | |||
| Medical or surgical procedures | 31 [of 33] (94) | 23 [of 25] (92) | 8 [of 8] (100) | |||
| Other technologies | 27 [of 35] (77) | 20 (74) | 6 [of 8] (78) | |||
| Organisational or administrative systems | 18 (51) | 17 (63) | 1 (13) | |||
| Public health interventions | 18 [of 35] (51) | 12 (44) | 6 [of 8] (75) | |||
| Use of medical device classification system | 18 (50) | 15 (56) | 3 (33) | |||
| N | Median (range) | N | Median (range) | N | Median (range) | |
| Average duration of assessment work (months) | ||||||
| Rapid review/response documents | 14 | 1.0 (0.2–6.0) | 11 | (0.2–6.0) | 3 | 1.2 (1.0–1.5) |
| Brief technical documents | 7 | 2.2 (1.5–8.0) | 5 | (1.5–8.0) | 2 | 2.9 (2.2–3.5) |
| Complete HTA or economic evaluation | 18 | 9.0 (1.0–18.0) | 14 | 10.5 (1.0–18.0) | 4 | 8.2 (4.5–10.5) |
| Proportion of HTA reports assessing MDs | 19 | 25% (5%–100%) | 14 | 51% (5%–100%) | 5 | 10% (5%–20%) |
a
All proportions based on the N = 36 (all agencies), N = 27 (MD specific agencies), N = 9 (Non MD specific agencies) unless otherwise indicated.
b
A positive response could be given to more than one item.